1
|
López-Rodríguez R, Bobolea I, Melero C, Rial MJ. Editorial: A multidisciplinary approach to treatment of severe chronic airway disease (CAD): focus on biomarkers. Front Allergy 2024; 5:1357886. [PMID: 38371921 PMCID: PMC10869584 DOI: 10.3389/falgy.2024.1357886] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/18/2023] [Accepted: 01/25/2024] [Indexed: 02/20/2024] Open
Affiliation(s)
| | - Irina Bobolea
- Department of Allergy, Institut Clínic Respiratorio, Hospital Clinic of Barcelona, Barcelona, Spain
- Network Biomedical Research Center for Respiratory Diseases, Carlos III Health Institute (ISCIII), Madrid, Spain
| | - Carlos Melero
- Department of Pulmonology, Research Institute Hospital 12 de Octubre, Madrid, Spain
| | - Manuel J. Rial
- Network Biomedical Research Center for Respiratory Diseases, Carlos III Health Institute (ISCIII), Madrid, Spain
- Department of Allergy, A Coruña University Hospital Complex (CHUAC), A Coruña, Spain
| |
Collapse
|
2
|
Bouza E, García Navarro JA, Alonso S, Duran Alonso JC, Escobar C, Fontecha Gómez BJ, Galvá Borrás MI, García Rojas AJ, Gómez Pavón FJ, Gracia D, Gutiérrez Rodríguez J, Kestler M, Martínez Cuervo F, Martín Sánchez FJ, Melero C, Escobar C, Menéndez Villanueva R, Muñoz P, Palomo E, Pérez-Castejón Garrote JM, Serra Rexach JA, Santaeugenia SJ, Tarazona Santabalbina FJ, Vidán Astiz MT. Infection control in long term care institutions for the elderly: A reflection document on the situation in Spain. Rev Esp Quimioter 2023. [PMID: 36987393 DOI: 10.37201/req/002.2023] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 03/30/2023]
Abstract
A progressively increasing percentage of the elderly live during the last years of their lives in nursing homes. Although these institutions are intended to mimic life at home as much as possible, they have characteristics that make them quite similar to a “nosocomiun”, i.e. an establishment for the treatment of the sick. The very coexistence among the elderly, the fact of sharing caregivers and the very significant exposure to third parties, together with the frequent predisposing diseases to infection in this population, make infection frequent among residents and also easily transmissible. This leads us to ask what can be done to prevent infection in this environment and more specifically what is the state of the art of the matter in a Western European nation such as ours. The Board of Trustees of the Health Sciences Foundation has asked itself a series of questions on the subject of infection prevention in Nursing Homes, the structure of procedures, the legislation available, compliance with the measures indicated, the best indicators of the processes and therefore, the need to promote in Spain a document of recommendations to avoid infections in this poplation whose morbidity and mortality need not be highlighted. To this end, a multidisciplinary group of experts in different aspects of this problem has been convened and asked the proposed questions. The questions were discussed by the group as a whole and led to a series of conclusions agreed upon by the participants. The results of the meeting are reported below.
Collapse
Affiliation(s)
- E Bouza
- Emilio Bouza, Instituto de Investigación Sanitaria Gregorio Marañón. C/ Dr. Esquerdo, 46 - 28007 Madrid, Spain.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
3
|
Cisneros C, Iturricastillo G, Martínez-Besteiro E, Eiros JM, Marcos C, Múgica V, Melero C, Martínez-Meca A, Landete P, Zamora E. Obstructive sleep apnea: The key for a better asthma control? Sleep Med 2023; 101:135-137. [PMID: 36375229 DOI: 10.1016/j.sleep.2022.10.015] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/14/2022] [Revised: 09/17/2022] [Accepted: 10/17/2022] [Indexed: 11/05/2022]
Abstract
INTRODUCTION Obstructive sleep apnea (OSA) is an important risk factor for poor asthma control. The objective of this study is to analyze the symptomatic control in asthmatic patients with OSA after using continuous positive airway pressure (CPAP). METHODS Patients were collected in a monographic asthma consult and a polygraphy was performed due to clinical suspicion or poor disease control. Asthma associated pathologies, as well as clinical and patient-perceived asthma control parameters were evaluated before and after the initiation of CPAP. RESULTS A hundred patients were included, 59% were women and 41% men. From them, 54% had severe OSA, 33% moderate OSA and 13% mild OSA, and 10% could not tolerate CPAP. Eighty four percent had a moderate or severe degree of asthma with fractional exhaled nitric oxide (FENO) 32 ± 24.6 ppm and an asthma control test (ACT) before CPAP of 19 ± 4. Asthma control before CPAP was good in 41% of patients, partial in 29%, and bad in 30%. After three or more months of CPAP, clinical asthma control was good in 70% (p < 0.001), perceived control by ACT after CPAP was 21 ± 4 (p < 0.001). When asked for their opinion, 51.5% referred clinical improvement after CPAP, no change in 46.5%. CONCLUSIONS The use of CPAP in asthmatic patients with OSA improves both clinical and perceived asthma control in a statistically significant way. Most patients had good adaptation to CPAP (90%) and 51.5% had clinical improvement.
Collapse
Affiliation(s)
- Carolina Cisneros
- Servicio de Neumología, Unidad de Asma de Alta Complejidad, Hospital Universitario de La Princesa, Madrid, Spain; Instituto de Investigación La Princesa, Unidad de Asma de Alta Complejidad, Madrid, Spain.
| | - Gorane Iturricastillo
- Servicio de Neumología, Unidad de Asma de Alta Complejidad, Hospital Universitario de La Princesa, Madrid, Spain.
| | - Elisa Martínez-Besteiro
- Servicio de Neumología, Unidad de Asma de Alta Complejidad, Hospital Universitario de La Princesa, Madrid, Spain.
| | - José María Eiros
- Servicio de Neumología, Unidad de Asma de Alta Complejidad, Hospital Universitario de La Princesa, Madrid, Spain.
| | - Celeste Marcos
- Servicio de Neumología, Unidad de Asma de Alta Complejidad, Hospital Universitario de La Princesa, Madrid, Spain.
| | - Victoria Múgica
- Servicio de Alergología, Unidad de Asma de Alta Complejidad, Hospital Universitario La Princesa, Madrid, Spain.
| | - Carlos Melero
- Instituto de Investigación La Princesa, Unidad de Asma de Alta Complejidad, Madrid, Spain.
| | - Ana Martínez-Meca
- Servicio de Neumología, Enfermera Unidad de Asma de Alta Complejidad, Hospital Universitario La Princesa, Madrid, Spain.
| | - Pedro Landete
- Servicio de Neumología, Unidad de Asma de Alta Complejidad, Hospital Universitario de La Princesa, Madrid, Spain.
| | - Enrique Zamora
- Servicio de Neumología, Unidad de Asma de Alta Complejidad, Hospital Universitario de La Princesa, Madrid, Spain.
| |
Collapse
|
4
|
Gentil‐Sergent C, Basset‐Mens C, Renaud‐Gentié C, Mottes C, Melero C, Launay A, Fantke P. Introducing ground cover management in pesticide emission modeling. Integr Environ Assess Manag 2022; 18:274-288. [PMID: 34160881 PMCID: PMC9291296 DOI: 10.1002/ieam.4482] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 12/02/2020] [Revised: 03/08/2021] [Accepted: 06/13/2021] [Indexed: 06/13/2023]
Abstract
Ground cover management (GCM) is an important agricultural practice used to reduce weed growth, erosion and runoff, and improve soil fertility. In the present study, an approach to account for GCM is proposed in the modeling of pesticide emissions to evaluate the environmental sustainability of agricultural practices. As a starting point, we include a cover crop compartment in the mass balance of calculating initial (within minutes after application) and secondary (including additional processes) pesticide emission fractions. The following parameters were considered: (i) cover crop occupation between the rows of main field crops, (ii) cover crop canopy density, and (iii) cover crop family. Two modalities of cover crop occupation and cover crop canopy density were tested for two crop growth stages, using scenarios without cover crops as control. From that, emission fractions and related ecotoxicity impacts were estimated for pesticides applied to tomato production in Martinique (French West Indies) and to grapevine cultivation in the Loire Valley (France). Our results demonstrate that, on average, the presence of a cover crop reduced the pesticide emission fraction reaching field soil by a factor of 3 compared with bare soil, independently of field crop and its growth stage, and cover crop occupation and density. When considering cover exported from the field, ecotoxicity impacts were reduced by approximately 65% and 90%, compared with bare soil for grapevine and tomato, respectively, regardless of the emission distribution used. Because additional processes may influence emission distributions under GCM, such as runoff, leaching, or preferential flow, further research is required to incorporate these processes consistently in our proposed GCM approach. Considering GCM in pesticide emission modeling highlights the potential of soil cover to reduce pesticide emissions to field soil and related freshwater ecotoxicity. Furthermore, the consideration of GCM as common farming practice allows the modeling of pesticide emissions in intercropping systems. Integr Environ Assess Manag 2022;18:274-288. © 2021 The Authors. Integrated Environmental Assessment and Management published by Wiley Periodicals LLC on behalf of Society of Environmental Toxicology & Chemistry (SETAC).
Collapse
Affiliation(s)
- Céline Gentil‐Sergent
- CIRAD, HortSysUniversity of MontpellierMontpellierFrance
- CIRAD, UPR HortSysELSALe LamentinMartiniqueFrance
| | - Claudine Basset‐Mens
- CIRAD, HortSysUniversity of MontpellierMontpellierFrance
- CIRAD, UPR HortSys, ELSAMontpellierFrance
| | | | - Charles Mottes
- CIRAD, HortSysUniversity of MontpellierMontpellierFrance
- CIRAD, UPR HortSysELSALe LamentinMartiniqueFrance
| | - Carlos Melero
- Quantitative Sustainability Assessment, Department of Technology, Management and Economics, Technical University of DenmarkProduktionstorvet Kongens LyngbyDenmark
| | - Arthur Launay
- CIRAD, HortSysUniversity of MontpellierMontpellierFrance
- CIRAD, UPR HortSysELSALe LamentinMartiniqueFrance
| | - Peter Fantke
- Quantitative Sustainability Assessment, Department of Technology, Management and Economics, Technical University of DenmarkProduktionstorvet Kongens LyngbyDenmark
| |
Collapse
|
5
|
Gentil-Sergent C, Basset-Mens C, Gaab J, Mottes C, Melero C, Fantke P. Quantifying pesticide emission fractions for tropical conditions. Chemosphere 2021; 275:130014. [PMID: 33662717 DOI: 10.1016/j.chemosphere.2021.130014] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/17/2020] [Revised: 02/13/2021] [Accepted: 02/17/2021] [Indexed: 06/12/2023]
Abstract
The inventory model 'PestLCI Consensus', originally developed for temperate conditions, estimates initial pesticide emission fractions to air, to off-field surfaces by drift deposition, and to field crop and field soil surfaces according to crop foliar interception characteristics. Since crop characteristics and application techniques differ in tropical conditions, these aspects need to be included in the model in support of evaluating pesticide emissions under tropical conditions. Based on published literature, a consistent set of crop foliar interception fractions was developed as function of crop characteristics and spraying techniques for tropical crops. In addition, we derived drift deposition fractions from published drift experiments specifically conducted under tropical conditions. Finally, we compiled a consistent set of pesticide emission fractions for application in life cycle assessment (LCA). Foliar interception fractions are strongly influenced by the spraying technique, particularly for hand-operated applications. Drift deposition fractions to off-field surfaces were derived for air blast sprayer on papaya and coffee, for boom sprayer on bean and soybean, for aerial application on soybean, sorghum, millet, corn and cotton, and for hand-operated application on cotton. Emission fractions vary for each combination of crop and application method. Drift deposition curves for missing crop-application method combinations can only partly be extrapolated from the set of considered combinations. Overall, our proposed foliar interception fractions and drift deposition fractions for various crops grown under tropical conditions allow to estimate pesticide emissions in support of assessing the environmental performance of agrifood systems in LCA with focus on tropical regions.
Collapse
Affiliation(s)
- Céline Gentil-Sergent
- CIRAD, UPR HortSys, ELSA, F-97232, Le Lamentin, Martinique, France; HortSys, Univ Montpellier, CIRAD, Montpellier, France.
| | - Claudine Basset-Mens
- HortSys, Univ Montpellier, CIRAD, Montpellier, France; CIRAD, UPR HortSys, ELSA, F-34398, Montpellier, France.
| | - Juliette Gaab
- CIRAD, UPR HortSys, ELSA, F-97232, Le Lamentin, Martinique, France; HortSys, Univ Montpellier, CIRAD, Montpellier, France.
| | - Charles Mottes
- CIRAD, UPR HortSys, ELSA, F-97232, Le Lamentin, Martinique, France; HortSys, Univ Montpellier, CIRAD, Montpellier, France.
| | - Carlos Melero
- Quantitative Sustainability Assessment, Department of Technology, Management and Economics, Technical University of Denmark, Produktionstorvet 424, 2800, Kgs. Lyngby, Denmark.
| | - Peter Fantke
- Quantitative Sustainability Assessment, Department of Technology, Management and Economics, Technical University of Denmark, Produktionstorvet 424, 2800, Kgs. Lyngby, Denmark.
| |
Collapse
|
6
|
Bobolea I, Bañas D, Melero C, de Andrés AI, Joksaite S, Sánchez-Herrero G. Exacerbation Rate Reduction with Mepolizumab, Stratified by Maintenance OCS Use and Eosinophil Levels. A Post-Hoc Analysis of DREAM and MENSA Studies. J Investig Allergol Clin Immunol 2021; 32:148-150. [PMID: 34085935 DOI: 10.18176/jiaci.0714] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
- I Bobolea
- Allergy Section, Severe Asthma Unit. Department of Pulmonology and Allergy, Hospital Clinic Barcelona- Institute for Health Research (IdiBAPS)
| | | | - C Melero
- Hospital 12 de Octubre Institute for Health Research (i+12), Madrid, Spain
| | | | | | | |
Collapse
|
7
|
Almonacid C, Melero C, López Viña A, Cisneros C, Pérez de Llano L, Plaza V, García-Rivero JL, Romero Falcón A, Ramos J, Bazús González T, Andrés Prado M, Muriel A. Effectiveness of Text Message Reminders on Adherence to Inhaled Therapy in Patients With Asthma: Prospective Multicenter Randomized Clinical Trial. JMIR Form Res 2021; 5:e12218. [PMID: 33560235 PMCID: PMC7902182 DOI: 10.2196/12218] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/22/2018] [Revised: 07/20/2019] [Accepted: 10/28/2020] [Indexed: 01/15/2023] Open
Abstract
Background Poor adherence to inhaled medication in asthma patients is of great concern. It is one of the main reasons for inadequate asthma control. Objective The goal of the research was to determine if motivational messages using short message service (SMS, or text) improved adherence to inhaled medication in patients with asthma. Methods A prospective multicenter randomized parallel-group clinical trial was conducted in 10 asthma clinics in Spain. Adherence was assessed with electronic monitors (Smartinhaler, Adherium Ltd) connected to inhalers. Patients in the SMS group received psychologist-developed motivational messages every 3 days for 6 months. Results There were 53 patients in the SMS group and 88 patients in the control group. After 6 months, mean electronic adherence was 70% (SD 17%) in the intervention group and 69% (SD 17%) in the control group (P=.82). Significant differences between the study groups in morning and evening adherence to inhaled therapy, asthma control, exhaled nitric oxide levels, or improvement of lung functions were not observed. Conclusions Motivational messages were not useful to improve adherence to inhaled asthma medication compared with usual care.
Collapse
Affiliation(s)
- Carlos Almonacid
- Department of Respiratory Medicine, Instituto Ramón y Cajal de Investigación Sanitaria, University of Alcala de Henares, Madrid, Spain
| | - Carlos Melero
- Department of Respiratory Medicine, Hospital Universitario 12 de Octubre, Institute for Health Research (i+12), Complutense University of Madrid, Madrid, Spain
| | - Antolín López Viña
- Department of Respiratory Medicine, Hospital Universitario Puerta de Hierro, Autonoma University of Madrid, Majadahonda, Spain
| | - Carolina Cisneros
- Department of Respiratory Medicine, Hospital Universitario La Princesa, Autónoma University of Madrid, Madrid, Spain
| | - Luis Pérez de Llano
- Department of Respiratory Medicine, Hospital Universitario Lucus Augusti, University of Lugo, Lugo, Spain
| | - Vicente Plaza
- Department of Respiratory Medicine, Hospital de la Santa Creu i Sant Pau, Institut d'Investigació Biomédica Sant Pau, Autònoma University of Barcelona, Barcelona, Spain
| | | | - Auxiliadora Romero Falcón
- Department of Respiratory Medicine, Hospital Universitario Reina Sofia, University of Cordoba, Córdoba, Spain
| | - Jacinto Ramos
- Department of Respiratory Medicine, Hospital Universitario de Salamanca, University of Salamanca, Salamanca, Spain
| | - Teresa Bazús González
- Department of Respiratory Medicine, Hospital Universitario Central de Asturias, University of Oviedo, Oviedo, Spain
| | - María Andrés Prado
- Department of Health Information Management, Fundación Jimenez Diaz, Madrid, Spain
| | - Alfonso Muriel
- Unit of Clinical Biostatistics, Instituto Ramón y Cajal de Investigación Sanitaria, Consorcio Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública, University of Alcala de Henares, Madrid, Spain
| |
Collapse
|
8
|
Luque L, Rodrigo T, García-García JM, Casals M, Millet JP, Caylà J, Orcau A, Agüero R, Alcázar J, Altet N, Altube L, Álvarez F, Anibarro L, Barrón M, Bermúdez P, Bikuña E, Blanquer R, Borderías L, Bustamante A, Calpe J, Caminero J, Cañas F, Casas F, Casas X, Cases E, Castejón N, Castrodeza R, Cebrián J, Cervera A, Ciruelos J, Delgado A, De Souza M, Díaz D, Domínguez M, Fernández B, Gallardo J, Gallego M, Clemente MG, García C, García F, Garros F, Gort A, Guerediaga A, Gullón J, Hidalgo C, Iglesias M, Jiménez G, Jiménez M, Kindelan J, Laparra J, López I, Lera R, Lloret T, Marín M, Lacasa XM, Martínez E, Martínez A, Medina J, Melero C, Milà C, Millet J, Mir I, Molina F, Morales C, Morales M, Moreno A, Moreno V, Muñoz A, Muñoz C, Muñoz J, Muñoz L, Oribe M, Parra I, Penas A, Pérez J, Rivas P, Rodríguez J, Ruiz-Manzano J, Sala J, Sandel D, Sánchez M, Sánchez M, Sánchez P, Santamaría I, Sanz F, Serrano A, Somoza M, Tabernero E, Trujillo E, Valencia E, Valiño P, Vargas A, Vidal I, Vidal R, Villanueva M, Villar A, Vizcaya M, Zabaleta M, Zubillaga G. Factors Associated With Extrapulmonary Tuberculosis in Spain and Its Distribution in Immigrant Population. Open Respiratory Archives 2020. [DOI: 10.1016/j.opresp.2020.04.004] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022] Open
|
9
|
Abstract
Objective: To describe resource use and costs of severe exacerbations in patients with severe asthma.Method: Secondary analysis of an observational, longitudinal, retrospective study that estimated the economic impact of severe asthma. The study was carried out in severe asthma units of the pulmonology and allergy services of 20 public hospitals (inclusion period: June to November 2016). The study included adult patients diagnosed with severe asthma according to the European Respiratory Society/American Thoracic Society consensus in the stable phase (no exacerbation during the last 2 months), and with at least one severe exacerbation during the study period (12 months). Healthcare resource use due to severe exacerbations (emergency visits, hospitalizations and pharmacological treatment) was recorded. The direct health costs associated with severe exacerbations were calculated by multiplying the resources used by the corresponding unit cost (in 2018 euros).Results: 134 patients with ≥1 severe exacerbation were included: 63% were female and the mean age was 54 years. 249 severe exacerbations were registered. There were 1.5 physician visits at primary care, hospital care and/or emergency room per episode, 13% of episodes required hospitalization, with a mean hospital stay of 7.2 days. Systemic corticosteroids were prescribed in 92% of exacerbations. The mean direct cost was €758.7/exacerbation (95% confidence interval: 556.8-1,011.1), of which 82% was due to hospitalizations (€623.3/episode). Considering only episodes requiring hospital admission, the mean cost increased by €4,997/exacerbation.Conclusions: It was estimated that the economic impact of a severe exacerbation in Spanish patients with severe asthma was €758.7/exacerbation.
Collapse
Affiliation(s)
- Santiago Quirce
- Department of Allergy, Hospital Universitario La Paz, IdiPAZ, and CIBER de Enfermedades Respiratorias CIBERES, Madrid, Spain
| | - Carlos Melero
- Instituto de Investigación (i + 12), Hospital Universitario 12 de Octubre, Madrid, Spain
| | - Alicia Huerta
- Departamento de Market Access, GlaxoSmithKline, Madrid, Spain
| | | | | |
Collapse
|
10
|
Cisneros C, Díaz-Campos RM, Marina N, Melero C, Padilla A, Pascual S, Pinedo C, Trisán A. Accreditation of specialized asthma units for adults in Spain: an applicable experience for the management of difficult-to-control asthma. J Asthma Allergy 2017; 10:163-169. [PMID: 28533690 PMCID: PMC5431694 DOI: 10.2147/jaa.s131506] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022] Open
Abstract
This paper, developed by consensus of staff physicians of accredited asthma units for the management of severe asthma, presents information on the process and requirements for already-existing asthma units to achieve official accreditation by the Spanish Society of Pneumology and Thoracic Surgery (SEPAR). Three levels of specialized asthma care have been established based on available resources, which include specialized units for highly complex asthma, specialized asthma units, and basic asthma units. Regardless of the level of accreditation obtained, the distinction of “excellence” could be granted when more requirements in the areas of provision of care, technical and human resources, training in asthma, and teaching and research activities were met at each level. The Spanish experience in the process of accreditation of specialized asthma units, particularly for the care of patients with difficult-to-control asthma, may be applicable to other health care settings.
Collapse
Affiliation(s)
| | | | - Núria Marina
- Asthma Unit, Laboratorio de Exploración Funcional, Department of Pneumology, Hospital Universitario Cruces, BioCruces, Barakaldo, Bizkaia
| | - Carlos Melero
- Service of Pneumology, Hospital Universitario 12 de Octubre, Madrid
| | | | | | - Celia Pinedo
- Service of Pneumology, Hospital Clínico San Carlos
| | - Andrea Trisán
- Service of Pneumology, Hospital Universitario Puerta de Hierro, Madrid, Spain
| |
Collapse
|
11
|
Plaza V, López-Viña A, Entrenas LM, Fernández-Rodríguez C, Melero C, Pérez-Llano L, Gutiérrez-Pereyra F, Tarragona E, Palomino R, Cosio BG. Differences in Adherence and Non-Adherence Behaviour Patterns to Inhaler Devices Between COPD and Asthma Patients. COPD 2016; 13:547-54. [PMID: 26788620 DOI: 10.3109/15412555.2015.1118449] [Citation(s) in RCA: 30] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
Differences between COPD and asthma may also differentially affect adherence to inhaled drugs in each disease. We aimed to determine differences in behaviour patterns of adherence and non-adherence to inhaled therapy between patients with COPD and patients with asthma using the Test of Adherence to Inhalers (TAI) questionnaire. A total of 910 patients (55% with asthma, 45% with COPD) participated in a cross-sectional multicentre study. Data recorded included sociodemographics, education level, asthma or COPD history, TAI score, the Asthma Control Test (ACT), the COPD Assessment Test (CAT) and spirometry. Asthma patients were statistically significant less adherents, 140 (28%) vs. 201 (49%), and the pattern of non-adherence was more frequently erratic (66.8% vs. 47.8%) and deliberate (47.2% vs. 34.1%) than COPD patients; however unwitting non-adherence was more frequently observed in COPD group (31.2% vs. 22.8%). Moreover, taking together all sample studied, only being younger than 50 years of age (OR 1.88 [95% CI: 1.26-2.81]) and active working status (OR 1.45 [95% CI: 1.00-2.09]) were risk factors for non-adherence in the multivariate analysis, while having asthma remained in the limits of the significance (OR 1.44 [95%CI: 0.97-2.14]). Even though non-adherence to inhalers is more frequently observed in asthma than in COPD patients and exhibited a different non-adherence patterns, these differences are more likely to be related to sociodemographic characteristics. However, differences in non-adherence patterns should be considered when designing specific education programmes tailored to each disease.
Collapse
Affiliation(s)
- Vicente Plaza
- a Department of Respiratory Medicine, Hospital de la Santa Creu i Sant Pau , Institut d'Investigació Biomédica Sant Pau (IIB Sant Pau), Universitat Autònoma de Barcelona, Department of Medicine , Barcelona , Spain
| | - Antolín López-Viña
- b Pulmonology Department, Hospital Universitario Puerta de Hierro , Majadahonda , Madrid , Spain
| | | | | | - Carlos Melero
- e Pulmonology Department, Hospital Universitario 12 de Octubre, Institute for Health Research (i+12) , Madrid , Spain
| | - Luis Pérez-Llano
- f Pulmonology Department, Hospital Universitario Lucus Augusti , Lugo , Spain
| | - Fernando Gutiérrez-Pereyra
- a Department of Respiratory Medicine, Hospital de la Santa Creu i Sant Pau , Institut d'Investigació Biomédica Sant Pau (IIB Sant Pau), Universitat Autònoma de Barcelona, Department of Medicine , Barcelona , Spain
| | - Eduard Tarragona
- g Medical Department, Chiesi Spain, L'Hospitalet de Llobregat , Barcelona , Spain
| | - Rosa Palomino
- h Área de investigación aplicada, GOC Networking , Barcelona , Spain
| | - Borja G Cosio
- i Department of Respiratory Medicine , Hospital Son Espases, Palma de Mallorca. CIBER Enfermedades Respiratorias (CIBERES) , Spain
| |
Collapse
|
12
|
Plaza V, Fernández-Rodríguez C, Melero C, Cosío BG, Entrenas LM, de Llano LP, Gutiérrez-Pereyra F, Tarragona E, Palomino R, López-Viña A. Validation of the 'Test of the Adherence to Inhalers' (TAI) for Asthma and COPD Patients. J Aerosol Med Pulm Drug Deliv 2015; 29:142-52. [PMID: 26230150 PMCID: PMC4841905 DOI: 10.1089/jamp.2015.1212] [Citation(s) in RCA: 117] [Impact Index Per Article: 13.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
Abstract
Background: To validate the ‘Test of Adherence to Inhalers’ (TAI), a 12-item questionnaire designed to assess the adherence to inhalers in patients with COPD or asthma. Methods: A total of 1009 patients with asthma or COPD participated in a cross-sectional multicenter study. Patients with electronic adherence ≥80% were defined as adherents. Construct validity, internal validity, and criterion validity were evaluated. Self-reported adherence was compared with the Morisky-Green questionnaire. Results: Factor analysis study demonstrated two factors, factor 1 was coincident with TAI patient domain (items 1 to 10) and factor 2 with TAI health-care professional domain (items 11 and 12). The Cronbach's alpha was 0.860 and the test-retest reliability 0.883. TAI scores correlated with electronic adherence (ρ=0.293, p=0.01). According to the best cut-off for 10 items (score 50, area under the ROC curve 0.7), 569 (62.5%) patients were classified as non-adherents. The non-adherence behavior pattern was: erratic 527 (57.9%), deliberate 375 (41.2%), and unwitting 242 (26.6%) patients. As compared to Morisky-Green test, TAI showed better psychometric properties. Conclusions: The TAI is a reliable and homogeneous questionnaire to identify easily non-adherence and to classify from a clinical perspective the barriers related to the use of inhalers in asthma and COPD.
Collapse
Affiliation(s)
- Vicente Plaza
- 1 Department of Respiratory Medicine, Hospital de la Santa Creu i Sant Pau. Institut d'Investigació Biomédica Sant Pau (IIB Sant Pau) , Universitat Autònoma de Barcelona, Department of Medicine, Barcelona, Spain
| | | | - Carlos Melero
- 3 Pulmonology Department, Instituto de Investigación, Hospital Universitario 12 de Octubre , Madrid, Spain
| | - Borja G Cosío
- 4 Department of Respiratory Medicine, Hospital Son Espases-IdISPa , Palma de Mallorca. CIBER Enfermedades Respiratorias (CIBERES), Spain
| | | | - Luis Pérez de Llano
- 6 Pulmonology Department, Hospital Universitario Lucus Augusti. Lugo , Spain
| | - Fernando Gutiérrez-Pereyra
- 1 Department of Respiratory Medicine, Hospital de la Santa Creu i Sant Pau. Institut d'Investigació Biomédica Sant Pau (IIB Sant Pau) , Universitat Autònoma de Barcelona, Department of Medicine, Barcelona, Spain
| | - Eduard Tarragona
- 7 Medical Department, Chiesi Spain, L'Hospitalet de Llobregat , Barcelona, Spain . Spain
| | - Rosa Palomino
- 8 Área de investigación aplicada, GOC Networking , Barcelona, Spain
| | - Antolín López-Viña
- 9 Pulmonology Department, Hospital Universitario Puerta de Hierro Majadahonda , Madrid, Spain
| | | |
Collapse
|
13
|
Salido M, Puiggros A, Corominas J, Iglesias M, Rodriguez-Rivera M, Melero C, Tusquets Trias Bes I, Albanell J, Serrano S, Servitja Tormo S, Espinet B. Comparison of the 2007 and 2013 Asco/Cap Guidelines for Her2 Ish Testing in Invasive Breast Cancer Patients. Ann Oncol 2014. [DOI: 10.1093/annonc/mdu359.7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
14
|
Baro M, Hernández I, López J, Vivanco J, Melero C. Éxito del empleo de rituximab en neumonía intersticial linfoide. An Pediatr (Barc) 2007. [DOI: 10.1016/s1695-4033(07)70466-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
15
|
Hernández M, Baro M, López J, Vivanco J, Melero C. Éxito del tratamiento con rituximab en el síndrome linfoproliferativo postrasplante. An Pediatr (Barc) 2007. [DOI: 10.1016/s1695-4033(07)70422-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
|
16
|
Hernández M, López J, Melero C, Vivanco J, Baro M. Linfohistiocitosis hemofagocítica refractaria. Evolución fatal por infección multisistémica por Fusarium. An Pediatr (Barc) 2007. [DOI: 10.1016/s1695-4033(07)70416-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
17
|
Abstract
We report the prenatal detection of an inherited paracentric inversion 16(q11.2q13).
Collapse
Affiliation(s)
- C Pérez
- General Lab, Laboratoris d'Anàlisis, Londres, 45 08029 Barcelona, Spain.
| | | | | | | | | | | |
Collapse
|
18
|
Castel V, Cañete A, Navarro S, García-Miguel P, Melero C, Acha T, Navajas A, Badal MD. Outcome of high-risk neuroblastoma using a dose intensity approach: improvement in initial but not in long-term results. Med Pediatr Oncol 2001; 37:537-42. [PMID: 11745893 DOI: 10.1002/mpo.1248] [Citation(s) in RCA: 41] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
BACKGROUND Stage 4 and MYCN amplified (MNA) neuroblastoma in children have a poor prognosis. Our aim was to increase initial and long-term response in this population. PROCEDURE High-risk children were studied according to the International Neuroblastoma Staging System, then treated with high-dose cyclophosphamide and high-dose carboplatin, followed by surgery and autologous stem cell transplant or maintenance chemotherapy. RESULTS From June 1992 to December 1998, 83 children were admitted in the study (72 stage 4> 1 year, 5 stage 4 MNA infants, and 6 MNA stage 3 children); tumor tissue was obtained from 73, MYCN was performed in 65, being amplified in 21 (32%). Induction chemotherapy was administered in the expected time in 35% of patients. Its toxicity was mainly hematologic followed by infections, and there were 3 chemotherapy-related deaths. Delayed surgery was performed on 60 patients with complete or >90% resection in 80% of cases. Chemotherapy plus surgery produced some response in 90% of patients, 53% were in CR/VGPR; 49 children received autologous SCT, and 16 received maintenance chemotherapy for 9 months. Follow-up ranges are 1-87 months, mean 30 months. S and EFS at 4 years are 0.33 (SD 0.02). CONCLUSIONS High-dose cyclophosphamide and high-dose carboplatin are effective in the initial treatment of neuroblastoma; combined with surgery they produce some response in most patients. Nevertheless, the CR/VGPR rate reaches only 53%. Survival time has also been prolonged but most patients relapse with metastases.
Collapse
Affiliation(s)
- V Castel
- Neuroblastoma Group, Spanish Society of Pediatric Oncology, Valencia, Spain.
| | | | | | | | | | | | | | | |
Collapse
|
19
|
Lloveras E, Lecumberri JM, Pérez C, Melero C, Zamora L, Sánchez MA, Solé F, Plaja A. A female infant with a 46,XX/48,XY, +8, +10 karyotype in prenatal diagnosis: a 'vanishing twin' phenomenon? Prenat Diagn 2001; 21:896-7. [PMID: 11746139 DOI: 10.1002/pd.174] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
20
|
Castel V, Cañete A, Melero C, Acha T, Navajas A, García-Miguel P, Contra T, Molina J, Galarón P, Cruz O. Results of the cooperative protocol (N-III-95) for metastatic relapses and refractory neuroblastoma. Med Pediatr Oncol 2000; 35:724-6. [PMID: 11107156 DOI: 10.1002/1096-911x(20001201)35:6<724::aid-mpo53>3.0.co;2-u] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
BACKGROUND Prognosis of relapsed and refractory neuroblastoma is uniformly fatal; new therapeutic approaches are needed. PROCEDURE Relapsed and refractory neuroblastoma patients were treated with continuous infusion chemotherapy combined with MIBG. RESULTS Over 4 years, 35 heavily pretreated patients were registered, 29 with bone or/and bone marrow metastases. Grade 3 or 4 hematologic toxicity was frequent, without toxic deaths. Sixteen patients responded. The probability of 5-year overall survival was 0.19. CONCLUSIONS This approach is feasible and toxicity manageable; it rescued some patients and prolonged their survival. It merits assay in newly diagnosed high-risk neuroblastoma patients.
Collapse
Affiliation(s)
- V Castel
- Unidad de Oncología Pediátrica, Hospital Infantil La Fe, Valencia, Spain
| | | | | | | | | | | | | | | | | | | |
Collapse
|
21
|
Castel V, García-Miguel P, Cañete A, Melero C, Navajas A, Ruíz-Jiménez JI, Navarro S, Badal MD. Prospective evaluation of the International Neuroblastoma Staging System (INSS) and the International Neuroblastoma Response Criteria (INRC) in a multicentre setting. Eur J Cancer 1999; 35:606-11. [PMID: 10492635 DOI: 10.1016/s0959-8049(98)00395-5] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
The aim of this study was to classify prospectively a series of neuroblastoma tumours according to the International Neuroblastoma Staging System (INSS) and the International Neuroblastoma Response Criteria (INRC) and to evaluate the difficulties and pitfalls involved in a multicentre setting. Each hospital provided their data for central review. The surgical procedures and their complications were reported. Kaplan-Meier estimates of survival and event-free survival were calculated according to stage and response to therapy. From June 1992 to December 1996, 194 patients were included in the study, with a mean age of 2 years. Initial studies were performed according to INSS recommendations without major problems. INSS stage was correctly applied to all patients except for 9 (95%). Post-operative complications were observed in 15 patients (8.3%). Response to therapy (INRC) was studied in 63 stage 4 patients, 11 of whom were not classified correctly (17%). Differences in survival according to stage (INSS) and group of response to therapy (INRC) were statistically significant (P < 0.001). In conclusion the INSS was easy to use and separated different prognostic groups. Surgical complications and mortality did not increase in this series because of using the INSS. The feasibility of INRC was evaluated in a small series of stage 4 patients and the designation of response was problematic in a relatively high proportion of cases. The prognostic value of the different responses was highly significant, but less informative than had been hoped for.
Collapse
Affiliation(s)
- V Castel
- Paediatric Oncology Unit, Hospital Infantil La Fe, Valencia, Spain.
| | | | | | | | | | | | | | | |
Collapse
|
22
|
Amor E, del Palacio A, Sanz F, Cuétara MS, Melero C, Torres MJ, Clemente J. [Fungemia in an immunodepressed pediatric patient]. Enferm Infecc Microbiol Clin 1998; 16:483-4. [PMID: 9918996] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/10/2023]
Affiliation(s)
- E Amor
- Servicio de Microbiología, Hospital de Móstoles, Madrid
| | | | | | | | | | | | | |
Collapse
|
23
|
de Pablo A, Díaz de Atauri MJ, Palomera J, Melero C. [Is the repetition of a sleep study with portable system without surveillance useful?]. Med Clin (Barc) 1997; 109:198-9. [PMID: 9257277] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
|
24
|
|
25
|
Ussetti P, Melero C, Rey R. [Secondary chemoprophylaxis in tuberculosis and AIDS]. Enferm Infecc Microbiol Clin 1996; 14:332. [PMID: 8924484] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
|
26
|
Castel V, García-Miguel P, Melero C, Navajas A, Navarro S, Molina J, Badal MD, Ruiz-Jimenez JI. The treatment of advanced neuroblastoma. Results of the Spanish Neuroblastoma Study Group (SNSG) studies. Eur J Cancer 1995; 31A:642-5. [PMID: 7576986 DOI: 10.1016/0959-8049(95)00072-q] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/26/2023]
Abstract
The Spanish Neuroblastoma Study Group has conducted a study on advanced neuroblastoma (N-I-87), which included 33 stage III and 60 stage IV neuroblastoma children more than 1 year of age, enrolled between October 1987 and April 1992. They were staged according to Evans and treated with induction chemotherapy (IC) consisting of 3 courses of cyclophosphamide-doxorubicin alternating with 3 of high-dose cisplatin-teniposide. Evaluation after IC and surgery demonstrated an overall response rate of 88% for stage III and 69% for stage IV. In the latter, complete responses and good partial responses were 33 and 14%, respectively. After surgery, children received maintenance chemotherapy (all stage III except 2 and 30 stage IV) or autologous bone marrow transplantation (ABMT) (11 stage IV), the distribution was not randomised. Probability of survival at 5 years was 0.60 +/- 0.12 for stage III and 0.24 +/- 0.07 for stage IV. A significant difference in survival at 5 years was found between "good responders" and "non-responders" to initial chemotherapy.
Collapse
Affiliation(s)
- V Castel
- Pediatric Oncology Unit, Hospital Infantil, Valencia, Spain
| | | | | | | | | | | | | | | |
Collapse
|
27
|
Castel V, Badal MD, Bezanilla JL, Llombart A, Ruiz-Jiménez JI, Sánchez de Toledo J, Melero C, Mulet J. Treatment of stage III neuroblastoma with emphasis on intensive induction chemotherapy: a report from the Neuroblastoma Group of the Spanish Society of Pediatric Oncology. Med Pediatr Oncol 1995; 24:29-35. [PMID: 7968789 DOI: 10.1002/mpo.2950240107] [Citation(s) in RCA: 18] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
Abstract
From October 87 to April 92, 172 children were admitted in the N-I-87 protocol of the Spanish Society of Pediatric Oncology for the diagnosis and treatment of neuroblastoma. Forty-eight were considered Evans stage III, 33 of them being older than 1 year. All children were treated with induction chemotherapy (IC) and surgery. IC consisted of three courses of high-dose cisplatin-VM-26 alternating with three further courses of cyclophosphamide-doxorubicin (CAD). Infants less than 1 year received the same drugs at lower doses. After surgery, maintenance chemotherapy was administered to all children during 14 months. It consisted of four pairs of drugs rotated every 4 weeks. Radiotherapy was administered exclusively to patients older than 1 year with residual tumor after IC and surgery. Response was evaluated after IC and surgery. In children older than 1 year, response was obtained in 28/33 (88%). Fifteen of them (47%) achieved complete remission (CR), seven (22%) good partial response (GPR), six (19%) partial response (PR); and in three patients (9%) there was progressive disease (PD). Actuarial survival at 48 months was 0.60 +/- 0.10 and EFS was 0.61 +/- 0.12. Audiologic impairment was considered the worst toxicity. In children less than 1 year the response rate to IC and surgery was 93% (14/15); nine infants obtained complete response and four had GPR. Only one patient experienced PD in the first 6 months of therapy and died. The other 14 are alive and well at a mean follow-up time of 48 months. Chemotherapy toxicity was mild and reversible.
Collapse
Affiliation(s)
- V Castel
- Pediatric Hematology/Oncology Unit, University Children's Hospital La Fe, Valencia, Spain
| | | | | | | | | | | | | | | |
Collapse
|
28
|
Torres-Valdivieso MJ, López J, Melero C, Vivanco JL, Cela E, Garcia A, Ruiz Contreras J, Serrano C. Hepatosplenic candidosis in an immunosuppressed patient responding to fluconazole. Mycoses 1994; 37:443-6. [PMID: 7659134 DOI: 10.1111/j.1439-0507.1994.tb00397.x] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/26/2023]
Affiliation(s)
- M J Torres-Valdivieso
- Pediatric Hemato-Oncology Section, Social Security Hospital 12 de Octubre, Madrid, Spain
| | | | | | | | | | | | | | | |
Collapse
|
29
|
Melero C, Rey R, Ussetti P, Muñoz L, Caballero J, Ortega A, Ramos A. Rifabutin vs rifampicin in the treatment of initial pulmonary tuberculosis. Follow-up at 5 years. ACTA ACUST UNITED AC 1994. [DOI: 10.1016/0962-8479(94)90741-2] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
30
|
Abstract
We describe 2 cases of proximal tubular defects induced by the administration of ifosfamide at a dosage of 6 g/m2/course over 2 days in children with a diagnosis of malignant mesenchymal tumors. This adverse effect could be minimized dividing dosage of the drug. However at present it is not clear if divided doses are completely safe.
Collapse
Affiliation(s)
- M J Torres Valdivieso
- Department of Pediatric Hematology-Oncology, Social Security Hospital 12 de Octubre, Madrid, Spain
| | | | | | | | | | | |
Collapse
|
31
|
Alvarez-Sala R, Segovia JG, Mareque M, Melero C, del Campo F. [Recurrent empyema caused by bronchial aspiration of a foreign body]. Rev Clin Esp 1992; 191:172. [PMID: 1502414] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
|
32
|
Melero C, López J, García-Muñoz F, Auray C, García MJ, Gil C, Valverde F, Aracil J, Bernacer M, Contra T. [Acute lymphoblastic leukemia, type T: therapeutic results]. An Esp Pediatr 1988; 29 Suppl 34:62-6. [PMID: 3214040] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]
|
33
|
Bernacer M, Aracil J, Contra T, Gil C, López J, López-Ibor B, Martín N, Melero C, Valverde F, Vecilla C. [Acute tumor lysis syndrome (ATLS) during remission induction treatment of Burkitt's lymphoma: study of 26 patients]. An Esp Pediatr 1988; 29 Suppl 34:109-12. [PMID: 3214014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]
Affiliation(s)
- M Bernacer
- Fundación Jiménez Diaz, Servicio de Pediatria, Madrid
| | | | | | | | | | | | | | | | | | | |
Collapse
|
34
|
López-Ibor B, Aracil J, Bernacer M, Contra T, Gil C, López J, Martín N, Melero C, Valverde F, Vecilla C. [Preleukemia in acute childhood lymphoblastic leukemia. Apropos of 3 cases]. An Esp Pediatr 1988; 29 Suppl 34:148-50. [PMID: 3214026] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]
|
35
|
López J, Melero C, Montalbán MA, García-Muñoz F, Nazario G, Valverde F, Gil C, Bernacer M, Aracil J, Contra T. [Therapeutic results in Burkitt's lymphoma]. An Esp Pediatr 1988; 29 Suppl 34:141-4. [PMID: 3214024] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]
Affiliation(s)
- J López
- Hospital Infantil 1. de Octubre, Madrid
| | | | | | | | | | | | | | | | | | | |
Collapse
|
36
|
Gil C, Valverde F, Contra T, Martín N, Bernacer M, Aracil J, Vecilla C, López J, Melero C. [Positive Philadelphia chromosome in childhood ALL]. An Esp Pediatr 1988; 29 Suppl 34:145-7. [PMID: 3214025] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]
Affiliation(s)
- C Gil
- Hospital Clínico Universitario, Departamento de Pediatría, Madrid
| | | | | | | | | | | | | | | | | |
Collapse
|
37
|
Jiménez Fernández F, Albañil R, López-Panero A, Gordillo I, Melero C, López J. [Hepatic hemangiomatosis: therapeutic embolization with polyvinyl alcohol (ivalon)]. An Esp Pediatr 1988; 28:588-90. [PMID: 3195865] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]
|
38
|
Gómez-León N, Alvarez-Sala R, Melero C, Molina A, Sánchez-Toril F, Daimiel R. [Woman of fertile age with pleural effusion and an interstitial lung pattern]. Rev Clin Esp 1988; 183:95-6. [PMID: 3175173] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]
|